Financhill
Back

Spyre Therapeutics Quote, Financials, Valuation and Earnings

Spyre Therapeutics Price Quote

$23.98
+0.06 (+0.25%)
(Updated: December 13, 2024 at 11:20 AM ET)

Spyre Therapeutics Key Stats

Sell
28
Spyre Therapeutics (SYRE) is a Sell

Day range:
$23.90 - $26.79
52-week range:
$14.22 - $47.97
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
821.89
P/B ratio:
8.18%

Volume:
736.5K
Avg. volume:
649.2K
1-year change:
44.97%
Market cap:
$1.4B
Revenue:
$886K
EPS:
$-4.12

How Much Does Spyre Therapeutics Make?

Data Unavailable

Is Spyre Therapeutics Growing As A Company?

Data Unavailable

Spyre Therapeutics Stock Price Performance

What Is Spyre Therapeutics 52-Week High & Low?

Spyre Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Spyre Therapeutics?

Is Spyre Therapeutics Cash Flow Positive?

  • What Is SYRE Cash Flow From Operations?
    Cash flow from operations (TTM) is -$151.2M
  • What Is Spyre Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $348.9M
  • What Is Spyre Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$218M

Spyre Therapeutics Return On Invested Capital

Data Unavailable

Spyre Therapeutics Earnings Date & Stock Price

Spyre Therapeutics Competitors

  • Who Are Spyre Therapeutics's Competitors?
    Below is a list of companies who compete with Spyre Therapeutics or are related in some way:
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Rocket Pharmaceuticals Inc (RCKT)
    • Theriva Biologics Inc (TOVX)

Spyre Therapeutics Dividend Yield

Spyre Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -57.77%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 10
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 58.63
Upside from Last Price: 145.09%

Major Shareholders

  • How many SYRE shares are owned by institutional investors?
    81.6M SYRE shares are owned by institutional investors
  • How many SYRE shares are owned by insiders?
    2.4M SYRE shares are owned by insiders